Following this afternoon’s announcement that the Drug Enforcement Agency (DEA) placed all illicit fentanyl analogues not already regulated by the Controlled Substances Act into Schedule 1, the American Society for Pharmacology and Experimental Therapeutics (ASPET) issued a statement.

Read the complete statement below.